63 related articles for article (PubMed ID: 15256234)
21. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
22. Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse.
Tasevski R; Gogos AJ; Mann GB
Breast; 2009 Oct; 18(5):322-6. PubMed ID: 19819141
[TBL] [Abstract][Full Text] [Related]
23. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
24. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
26. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
27. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
28. [Sentinel lymph node biopsy in breast cancer].
Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R
Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777
[TBL] [Abstract][Full Text] [Related]
29. Biopsy type does not influence sentinel lymph node status.
Chagpar AB; Scoggins CR; Sahoo S; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Am J Surg; 2005 Oct; 190(4):551-6. PubMed ID: 16164918
[TBL] [Abstract][Full Text] [Related]
30. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
31. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
32. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
34. The role of sentinel lymph-node biopsy (SLNB) in the treatment of breast cancer.
Marrazzo A; Taormina P; David M; Casà L; Lo Gerfo D; Noto A; Riili I; Ficola U; Russo L
Chir Ital; 2006; 58(3):299-304. PubMed ID: 16845865
[TBL] [Abstract][Full Text] [Related]
35. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
[TBL] [Abstract][Full Text] [Related]
36. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
[TBL] [Abstract][Full Text] [Related]
37. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
[TBL] [Abstract][Full Text] [Related]
40. Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer.
O'Leary DP; O'Brien O; Relihan N; McCarthy J; Ryan M; Barry J; Kelly LM; Redmond HP
Br J Surg; 2012 Jun; 99(6):807-12. PubMed ID: 22473359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
